Literature DB >> 9204215

Anti-galectin-1 autoantibodies in serum of patients with neurological diseases.

D Lutomski1, R Joubert-Caron, C Lefebure, J Salama, C Belin, D Bladier, M Caron.   

Abstract

The presence of autoantibodies to human brain galectin-1 was investigated in serum from patients with multiple sclerosis, patients with or without evidence of other neurological disorders, and healthy controls, using an ELISA on purified brain galectin-1. Levels of autoantibodies to galectin-1 were significantly higher in patients than in healthy controls. Comparison of levels of anti-galectin-1 and anti-idiotypic antibodies mimicking human brain galectin-1 (L-IgG) showed that the highest levels of autoantibodies were present in patients with low levels of L-IgG. This finding can be explained by hypothesizing that the concentration of autoantibodies to galectin-1 is possibly associated with impairment of the regulation of the immune system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9204215     DOI: 10.1016/s0009-8981(97)06544-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  12 in total

Review 1.  Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses.

Authors:  Gabriel A Rabinovich; Marta A Toscano; Juan M Ilarregui; Natalia Rubinstein
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

2.  Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases.

Authors:  Alexandra K Brooks; Tiffany M Janda; Marcus A Lawson; Jennifer L Rytych; Robin A Smith; Cecilia Ocampo-Solis; Robert H McCusker
Journal:  Brain Behav Immun       Date:  2017-02-16       Impact factor: 7.217

3.  Anti-Galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries.

Authors:  E Jensen-Jarolim; C Neumann; G Oberhuber; R Gscheidlinger; C Neuchrist; W Reinisch; R I Zuberi; E Penner; F T Liu; G Boltz-Nitulescu
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

4.  Natural autoantibody to galectin-9 in normal human sera.

Authors:  K Suk; D Y Hwang; M S Lee
Journal:  J Clin Immunol       Date:  1999-05       Impact factor: 8.317

5.  Anti-galectin-1 autoantibodies in human Trypanosoma cruzi infection: differential expression of this beta-galactoside-binding protein in cardiac Chagas' disease.

Authors:  L Giordanengo; S Gea; G Barbieri; G A Rabinovich
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

Review 6.  Galectin-1 plays essential roles in adult mammalian nervous tissues. Roles of oxidized galectin-1.

Authors:  Hidenori Horie; Toshihiko Kadoya
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

7.  From examining the relationship between (corona)viral adhesins and galectins to glyco-perspectives.

Authors:  Michael L Klein; Antonio Romero; Herbert Kaltner; Virgil Percec; Hans-Joachim Gabius
Journal:  Biophys J       Date:  2020-11-26       Impact factor: 4.033

8.  Animal Galectins and Plant Lectins as Tools for Studies in Neurosciences.

Authors:  João Ronielly Campêlo Araújo; Cauê Barbosa Coelho; Adriana Rolim Campos; Renato de Azevedo Moreira; Ana Cristina de Oliveira Monteiro-Moreira
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 9.  Galectins in Chagas Disease: A Missing Link Between Trypanosoma cruzi Infection, Inflammation, and Tissue Damage.

Authors:  Carolina V Poncini; Alejandro F Benatar; Karina A Gomez; Gabriel A Rabinovich
Journal:  Front Microbiol       Date:  2022-01-03       Impact factor: 5.640

10.  A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.

Authors:  Julia Y Wang; Michael W Roehrl; Victor B Roehrl; Michael H Roehrl
Journal:  bioRxiv       Date:  2021-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.